Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer
Status:
Recruiting
Trial end date:
2021-01-30
Target enrollment:
Participant gender:
Summary
Tranexamic acid has been used in surgery for more than 30 years. It's effect on reducing
bleeding and blood transfusing has been demonstrated.
In our hospital, the amount of cytorsductive surgery for ovarian cancer is big. During the
perioperation , bleeding probability is high, and the supply of blood products is limited. In
order to reduce bleeding, we're planning to use tranexamic acid in the operations.
In this experiment, we will observe the efficacy of tranexamic acid in cytoreductive surgery
for ovarian cancer, find the best dosage which can reach the desired effect, and the possible
side-effect.